Immune-Mediated Inflammatory Diseases Unit

Specialists in complex inflammatory skin conditions

The Immune-Mediated Inflammatory Diseases Unit at the Publio Cordón Memorial Hospital is headed by a dermatology specialist with particular expertise in chronic inflammatory conditions and advanced therapies.

This is a highly specialised unit focused on the diagnosis and treatment of skin conditions of autoimmune and inflammatory origin that require expert assessment, close monitoring and individualised treatment decisions.

The unit deals with conditions of high clinical complexity, both in terms of the severity of symptoms and their functional, psychological and social impact.

From the very first contact, the care model is based on sound medical judgement, structured planning and clear communication, enabling patients to understand each stage of the process and make decisions with confidence.

Specialist care for difficult-to-control inflammatory skin conditions

This unit is aimed at patients with chronic inflammatory conditions who do not respond adequately to conventional treatments, have moderate or severe forms of the condition, or require advanced systemic therapies under expert supervision.

A specialist assessment is particularly recommended in cases of extensive disease involvement, recurrent flare-ups, significant impairment of quality of life, or where there is a need to initiate biologic treatments.

Unlike general care, the unit offers a comprehensive approach that combines accurate diagnosis, specific immunological assessment and access to innovative therapies with carefully established indications.

Conditions requiring expert assessment

The unit routinely manages immune-mediated inflammatory diseases that require structured clinical management and specialist follow-up.

Each case is analysed on an individual basis, taking into account the patient’s full medical history, previous course of the condition, treatments received and the options available at any given time.

Among the most common conditions are:

• Moderate and severe psoriasis

• Severe or refractory atopic dermatitis

• Hidradenitis suppurativa

• Complex inflammatory autoimmune dermatoses

The therapeutic indication is always established on the basis of rigorous clinical criteria, taking into account expected benefits, the safety profile and realistic medium- and long-term control objectives.

Accurate diagnosis and personalised treatment planning

The care process begins with a specialist consultation during which a detailed clinical assessment is carried out, along with an analysis of the inflammatory pattern and a thorough review of the patient’s medical history and previous treatments.

Where indicated, specific immunological tests, skin biopsies and supplementary tests are carried out to confirm the diagnosis, classify the severity and determine the most appropriate treatment strategy.

Treatment planning is carried out in a structured manner and, in complex cases, in coordination with other hospital specialities where systemic manifestations or associated comorbidities are present.

Every decision is made following a well-founded clinical analysis and an individual assessment of the risk-benefit balance.

Advanced treatments indicated on the basis of clinical benefit

The unit has access to innovative therapies, including state-of-the-art biologics and immunomodulators, which are indicated where there is a proven clinical benefit and a need for sustained control of inflammation.

Treatment is tailored to the individual’s clinical profile, taking into account disease activity, previous response to other treatment options and long-term safety criteria.

Follow-up is protocol-based, with regular check-ups that allow the treatment strategy to be adjusted where necessary.

The aim is to achieve stable and sustained control of the disease, reduce the frequency of flare-ups and improve quality of life through medically justified treatment planning.

Highly specialised care and ongoing clinical support

The unit comprises dermatologists who specialise specifically in immune-mediated inflammatory diseases and have extensive experience in managing complex skin conditions.

This level of subspecialisation enables us to provide expert assessments from the very first consultation, with clear recommendations and strategies tailored to each clinical situation.

Follow-up is structured and dynamic, with regular reviews of the patient’s progress to adjust treatment according to the response achieved.

We take the time necessary to explain the diagnosis, the treatment options and the rationale behind each medical decision, enabling patients to make an informed and confident choice.

The unit provides ongoing monitoring and support throughout all stages of the disease, ensuring clinical stability and predictability in the patient’s progress.